- call +1-201-465-4211
- email sales@mrinsights.biz
Cancer stem cells (CSCs) refer to the cells obtained from tumor that posses potential to reproduce all types of cancer cells found in a cancer sample. Cancer stem cells are planned to grow in tumors as a separate population and thereby cause deterioration and metastasis of existing tumor through generation of new tumor. Thus, with advancement in technology especially in cancer stem cells research area, therapies specific to targeting cancer stem cells are expected to improve quality of life and survival cases of cancer patients with metastatic diseases.
Scope of the Report:
This report studies the Cancer Stem Cell market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Cancer Stem Cell market by product type and applications/end industries.
North America was the leading revenue contributor of the cancer stem cells market in 2016 due to presence of a substantial number of organizations engaged in conducting R&D activities related to stem cell therapy. There are several internationally recognized hospitals and medical institutes, such as Cancer Treatment Centers of America at Midwestern Regional Medical Center, which offer stem cell transplant therapies.
Asia Pacific is expected to be a promising region in the arena owing to presence of several organizations in the region that focus on R&D of stem cells. Moreover, funding agencies are providing grants to research communities to accelerate their scientific research on cancer stem cells in Asian countries.
The global Cancer Stem Cell market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Cancer Stem Cell.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
Thermo Fisher Scientific, Inc.
AbbVie, Inc.
Merck KGaA
Bionomics
Lonza
Stemline Therapeutics, Inc.
Miltenyi Biotec
PromoCell GmbH
MacroGenics, Inc.
OncoMed Pharmaceuticals, Inc.
Irvine Scientific
STEMCELL Technologies Inc.
Sino Biological Inc.
BIOTIME, Inc.
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Cell Culturing
Cell Separation
Cell Analysis
Molecular Analysis
Others
Market Segment by Applications, can be divided into
Stem Cell Based Cancer Therapy
Targeted CSCs
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Cancer Stem Cell Market Overview
1.1 Product Overview and Scope of Cancer Stem Cell
1.2 Classification of Cancer Stem Cell by Types
1.2.1 Global Cancer Stem Cell Revenue Comparison by Types (2017-2023)
1.2.2 Global Cancer Stem Cell Revenue Market Share by Types in 2017
1.2.3 Cell Culturing
1.2.4 Cell Separation
1.2.5 Cell Analysis
1.2.6 Molecular Analysis
1.2.7 Others
1.3 Global Cancer Stem Cell Market by Application
1.3.1 Global Cancer Stem Cell Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Stem Cell Based Cancer Therapy
1.3.3 Targeted CSCs
1.4 Global Cancer Stem Cell Market by Regions
1.4.1 Global Cancer Stem Cell Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Cancer Stem Cell Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Cancer Stem Cell Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Cancer Stem Cell Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Cancer Stem Cell Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Cancer Stem Cell Status and Prospect (2013-2023)
1.5 Global Market Size of Cancer Stem Cell (2013-2023)
2 Manufacturers Profiles
2.1 Thermo Fisher Scientific, Inc.
2.1.1 Business Overview
2.1.2 Cancer Stem Cell Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Thermo Fisher Scientific, Inc. Cancer Stem Cell Revenue, Gross Margin and Market Share (2016-2017)
2.2 AbbVie, Inc.
2.2.1 Business Overview
2.2.2 Cancer Stem Cell Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 AbbVie, Inc. Cancer Stem Cell Revenue, Gross Margin and Market Share (2016-2017)
2.3 Merck KGaA
2.3.1 Business Overview
2.3.2 Cancer Stem Cell Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Merck KGaA Cancer Stem Cell Revenue, Gross Margin and Market Share (2016-2017)
2.4 Bionomics
2.4.1 Business Overview
2.4.2 Cancer Stem Cell Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Bionomics Cancer Stem Cell Revenue, Gross Margin and Market Share (2016-2017)
2.5 Lonza
2.5.1 Business Overview
2.5.2 Cancer Stem Cell Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Lonza Cancer Stem Cell Revenue, Gross Margin and Market Share (2016-2017)
2.6 Stemline Therapeutics, Inc.
2.6.1 Business Overview
2.6.2 Cancer Stem Cell Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Stemline Therapeutics, Inc. Cancer Stem Cell Revenue, Gross Margin and Market Share (2016-2017)
2.7 Miltenyi Biotec
2.7.1 Business Overview
2.7.2 Cancer Stem Cell Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Miltenyi Biotec Cancer Stem Cell Revenue, Gross Margin and Market Share (2016-2017)
2.8 PromoCell GmbH
2.8.1 Business Overview
2.8.2 Cancer Stem Cell Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 PromoCell GmbH Cancer Stem Cell Revenue, Gross Margin and Market Share (2016-2017)
2.9 MacroGenics, Inc.
2.9.1 Business Overview
2.9.2 Cancer Stem Cell Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 MacroGenics, Inc. Cancer Stem Cell Revenue, Gross Margin and Market Share (2016-2017)
2.10 OncoMed Pharmaceuticals, Inc.
2.10.1 Business Overview
2.10.2 Cancer Stem Cell Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 OncoMed Pharmaceuticals, Inc. Cancer Stem Cell Revenue, Gross Margin and Market Share (2016-2017)
2.11 Irvine Scientific
2.11.1 Business Overview
2.11.2 Cancer Stem Cell Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Irvine Scientific Cancer Stem Cell Revenue, Gross Margin and Market Share (2016-2017)
2.12 STEMCELL Technologies Inc.
2.12.1 Business Overview
2.12.2 Cancer Stem Cell Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 STEMCELL Technologies Inc. Cancer Stem Cell Revenue, Gross Margin and Market Share (2016-2017)
2.13 Sino Biological Inc.
2.13.1 Business Overview
2.13.2 Cancer Stem Cell Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Sino Biological Inc. Cancer Stem Cell Revenue, Gross Margin and Market Share (2016-2017)
2.14 BIOTIME, Inc.
2.14.1 Business Overview
2.14.2 Cancer Stem Cell Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 BIOTIME, Inc. Cancer Stem Cell Revenue, Gross Margin and Market Share (2016-2017)
3 Global Cancer Stem Cell Market Competition, by Players
3.1 Global Cancer Stem Cell Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Cancer Stem Cell Players Market Share
3.2.2 Top 10 Cancer Stem Cell Players Market Share
3.3 Market Competition Trend
4 Global Cancer Stem Cell Market Size by Regions
4.1 Global Cancer Stem Cell Revenue and Market Share by Regions
4.2 North America Cancer Stem Cell Revenue and Growth Rate (2013-2018)
4.3 Europe Cancer Stem Cell Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Cancer Stem Cell Revenue and Growth Rate (2013-2018)
4.5 South America Cancer Stem Cell Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Cancer Stem Cell Revenue and Growth Rate (2013-2018)
5 North America Cancer Stem Cell Revenue by Countries
5.1 North America Cancer Stem Cell Revenue by Countries (2013-2018)
5.2 USA Cancer Stem Cell Revenue and Growth Rate (2013-2018)
5.3 Canada Cancer Stem Cell Revenue and Growth Rate (2013-2018)
5.4 Mexico Cancer Stem Cell Revenue and Growth Rate (2013-2018)
6 Europe Cancer Stem Cell Revenue by Countries
6.1 Europe Cancer Stem Cell Revenue by Countries (2013-2018)
6.2 Germany Cancer Stem Cell Revenue and Growth Rate (2013-2018)
6.3 UK Cancer Stem Cell Revenue and Growth Rate (2013-2018)
6.4 France Cancer Stem Cell Revenue and Growth Rate (2013-2018)
6.5 Russia Cancer Stem Cell Revenue and Growth Rate (2013-2018)
6.6 Italy Cancer Stem Cell Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Cancer Stem Cell Revenue by Countries
7.1 Asia-Pacific Cancer Stem Cell Revenue by Countries (2013-2018)
7.2 China Cancer Stem Cell Revenue and Growth Rate (2013-2018)
7.3 Japan Cancer Stem Cell Revenue and Growth Rate (2013-2018)
7.4 Korea Cancer Stem Cell Revenue and Growth Rate (2013-2018)
7.5 India Cancer Stem Cell Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Cancer Stem Cell Revenue and Growth Rate (2013-2018)
8 South America Cancer Stem Cell Revenue by Countries
8.1 South America Cancer Stem Cell Revenue by Countries (2013-2018)
8.2 Brazil Cancer Stem Cell Revenue and Growth Rate (2013-2018)
8.3 Argentina Cancer Stem Cell Revenue and Growth Rate (2013-2018)
8.4 Colombia Cancer Stem Cell Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Cancer Stem Cell by Countries
9.1 Middle East and Africa Cancer Stem Cell Revenue by Countries (2013-2018)
9.2 Saudi Arabia Cancer Stem Cell Revenue and Growth Rate (2013-2018)
9.3 UAE Cancer Stem Cell Revenue and Growth Rate (2013-2018)
9.4 Egypt Cancer Stem Cell Revenue and Growth Rate (2013-2018)
9.5 Nigeria Cancer Stem Cell Revenue and Growth Rate (2013-2018)
9.6 South Africa Cancer Stem Cell Revenue and Growth Rate (2013-2018)
10 Global Cancer Stem Cell Market Segment by Type
10.1 Global Cancer Stem Cell Revenue and Market Share by Type (2013-2018)
10.2 Global Cancer Stem Cell Market Forecast by Type (2018-2023)
10.3 Cell Culturing Revenue Growth Rate (2013-2023)
10.4 Cell Separation Revenue Growth Rate (2013-2023)
10.5 Cell Analysis Revenue Growth Rate (2013-2023)
10.6 Molecular Analysis Revenue Growth Rate (2013-2023)
10.7 Others Revenue Growth Rate (2013-2023)
11 Global Cancer Stem Cell Market Segment by Application
11.1 Global Cancer Stem Cell Revenue Market Share by Application (2013-2018)
11.2 Cancer Stem Cell Market Forecast by Application (2018-2023)
11.3 Stem Cell Based Cancer Therapy Revenue Growth (2013-2018)
11.4 Targeted CSCs Revenue Growth (2013-2018)
12 Global Cancer Stem Cell Market Size Forecast (2018-2023)
12.1 Global Cancer Stem Cell Market Size Forecast (2018-2023)
12.2 Global Cancer Stem Cell Market Forecast by Regions (2018-2023)
12.3 North America Cancer Stem Cell Revenue Market Forecast (2018-2023)
12.4 Europe Cancer Stem Cell Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Cancer Stem Cell Revenue Market Forecast (2018-2023)
12.6 South America Cancer Stem Cell Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Cancer Stem Cell Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Cancer Stem Cell Picture
Table Product Specifications of Cancer Stem Cell
Table Global Cancer Stem Cell and Revenue (Million USD) Market Split by Product Type
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
